Avian Influenza Vaccines Market Potential Growth, Share, Demand, and Key Player Analysis

Avian influenza, commonly known as bird flu, is a viral virus that transmits from birds to other animals including people. The virus was discovered for the first time in China. In the following year, during an outbreak in Hong Kong, the Asian H5N1 strain was discovered, and it has since spread throughout Europe, Asia, North and South America, Africa, and the Middle East. Based on its molecular structure, avian influenza can be classified as highly pathogenic or low pathogenic. The virus is classified as H5N1, H7N3, H7N7, H7N9, and H9N2 depending on the strains. Furthermore, the virus of type A of subtype H5N1 is currently being studied as the most virulent avian influenza virus.

Full access of report:
https://www.databridgemarketresearch.com/reports/global-avian-influenza-vaccines-market

Data Bridge Market Research analyses that the avian influenza vaccines market was valued at USD 124.53 million in 2021 and is expected to reach USD 196.25 million by 2029, registering a CAGR of 5.85% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Top Trending Reports:

https://1234submission1234.blogspot.com/2024/02/radiofrequency-rf-microneedling-market_8.html

https://marketingofreport.wordpress.com/2024/02/09/818/

https://1234submission1234.blogspot.com/2024/02/bacteriophages-therapy-market-potential.html

Avian influenza is an infectious disease caused by the type-A virus found in birds. Aquatic birds are the virus's most common carrier. The avian influenza type A virus is characterized as either neuraminidase (NA) or hemagglutinin (HA) based on protein remains on its surface (HA). It is classified as either highly pathogenic or low pathogenic based on molecular features. If the virus gets into the eyes, nose, or mouth, it can cause serious illness. For infection prevention and treatment, the antiviral drugs oseltamivir and zanamivir are included in the Avian Influenza Vaccines. Ducks, chickens, geese, and other birds are all known to consume it.

click here for sample report:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-avian-influenza-vaccines-market

players operating in the avian influenza vaccines market are:

Sanofi (France)
F. Hoffmann-La Roche Ltd. (Switzerland)
Mallinckrodt (US)
Elanco (US)
Boehringer Ingelheim International GmbH. (Germany)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)

Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.